Global Prostate Cancer Market to Reap USD 29.52 Billion By 2030 | Infinium Global Research

Infinium Global Research, a leading authority in comprehensive market studies, has released an exhaustive report detailing the Global Prostate Cancer Market. The report provides an extensive analysis of market segments, sub-segments, drivers, restraints, and macro indicators, offering a profound understanding of the trends, forecasts, and dollar values shaping the Prostate Cancer Market landscape.

To Know More Request a Sample of this Report: https://www.infiniumglobalresearch.com/market-reports/sample-request/1174

Market Overview and Projected Growth

The global Prostate Cancer Market, valued at USD 12.32 billion in 2022, is expected to reach an impressive USD 29.52 billion by 2030, reflecting a remarkable Compound Annual Growth Rate (CAGR) of 10.0% during the forecast period from 2023 to 2030.

Understanding Prostate Cancer

Prostate cancer is a prevalent form of cancer affecting males, specifically targeting the prostate gland. This malignancy involves uncontrollable cell growth within the gland, leading to tumors. Risk factors include age, genetics, cultural background, and gene mutations. While early stages might be asymptomatic, advanced stages can result in pain and urinary issues. Diagnosis typically involves PSA testing and biopsy, with treatments including surgery, radiation, hormone therapy, chemotherapy, and immunotherapy. Early detection is key for improved outcomes, emphasizing the importance of regular medical consultations and screenings.

Market Drivers and Limitations

The escalating incidence and prevalence of prostate cancer, primarily due to an aging population, advanced diagnostic techniques, increased awareness, and screening initiatives, drive the market's expansion. Advancements in medical technology, such as multiparametric Magnetic Resonance Imaging (MRI) and liquid biopsies, have revolutionized prostate cancer identification and staging, contributing to market growth. However, in regions with limited healthcare expenditure, cost becomes a hindrance, limiting access to timely and appropriate treatment.

Opportunities and Regional Insights

North America is anticipated to lead the Prostate Cancer Market during the forecast period due to a growing aged population, increasing prostate cancer cases, and the launch of promising medications in biologics and hormone therapy sectors. The region's projected launch of pipeline medications is expected to further fuel market growth. The Asia Pacific region is also witnessing significant market growth due to an expanding population, unhealthy lifestyles, and increased healthcare expenditure.

Segments Covered in the Report

The comprehensive report segments the global Prostate Cancer Market based on drug class (hormonal therapy, immunotherapy, targeted therapy, others), distribution channels (hospital pharmacies, drug store & retail pharmacies, online pharmacies, others), and end users (clinic, hospital, others).

Profiles of Key Market Players

The report features detailed profiles of leading industry players, including Pfizer Inc., AbbVie Inc., AstraZeneca, Johnson & Johnson Services, Merck & Co., Sanofi, Bayer AG, Clovis Oncology, Eli Lilly and Company, Astellas Pharma Inc., offering a comprehensive insight into their strategies and market positioning.

Enquire Here Get Customization & Check the Discount for the Report @ https://www.infiniumglobalresearch.com/market-reports/customization/1174

Table of Content

Chapter 1. Preface

1.1. Report Description

1.2. Research Methods

1.3. Research Approaches

Chapter 2. Executive Summary

2.1. Prostate Cancer Market Highlights

2.2. Prostate Cancer Market Projection

2.3. Prostate Cancer Market Regional Highlights

Chapter 3. Global Prostate Cancer Market Overview

3.1. Introduction

3.2. Market Dynamics

3.2.1. Drivers

3.2.2. Restraints

3.2.3. Opportunities

3.3. Porter`s Five Forces Analysis

3.4. IGR-Growth Matrix Analysis

3.4.1. IGR-Growth Matrix Analysis by Drug Class

3.4.2. IGR-Growth Matrix Analysis by Distribution Channel

3.4.3. IGR-Growth Matrix Analysis by End User

3.4.4. IGR-Growth Matrix Analysis by Region

3.5. Value Chain Analysis of Prostate Cancer Market

Chapter 4. Prostate Cancer Market Macro Indicator Analysis

Chapter 5. Company Profiles and Competitive Landscape

5.1. Competitive Landscape in the Global Prostate Cancer Market

5.2. Companies Profiles

5.2.1. Pfizer Inc.

5.2.2. AbbVie Inc.

5.2.3. AstraZeneca

5.2.4. Johnson & Johnson Services, Inc.

5.2.5. Merck & Co., Inc.

5.2.6. Sanofi

5.2.7. Bayer AG

5.2.8. Clovis Oncology, Inc.

5.2.9. Eli Lilly and Company

5.2.10. Astellas Pharma Inc.

Chapter 6. Global Prostate Cancer Market by Drug Class

6.1. Hormonal Therapy

6.2. Immunotherapy

6.3. Targeted Therapy

6.4. Others

Chapter 7. Global Prostate Cancer Market by Distribution Channel

7.1. Hospital Pharmacies

7.2. Drug Store & Retail Pharmacies

7.3. Online Pharmacies

7.4. Others

Chapter 8. Global Prostate Cancer Market by End User

8.1. Clinic

8.2. Hospital

8.3. Others

Chapter 9. Global Prostate Cancer Market by Region 2023-2030

9.1. North America

9.1.1. North America Prostate Cancer Market by Drug Class

9.1.2. North America Prostate Cancer Market by Distribution Channel

9.1.3. North America Prostate Cancer Market by End User

9.1.4. North America Prostate Cancer Market by Country

9.1.4.1. The U.S. Prostate Cancer Market

9.1.4.1.1. The U.S. Prostate Cancer Market by Drug Class

9.1.4.1.2. The U.S. Prostate Cancer Market by Distribution Channel

9.1.4.1.3. The U.S. Prostate Cancer Market by End User

9.1.4.2. Canada Prostate Cancer Market

9.1.4.2.1. Canada Prostate Cancer Market by Drug Class

9.1.4.2.2. Canada Prostate Cancer Market by Distribution Channel

9.1.4.2.3. Canada Prostate Cancer Market by End User

9.1.4.3. Mexico Prostate Cancer Market

9.1.4.3.1. Mexico Prostate Cancer Market by Drug Class

9.1.4.3.2. Mexico Prostate Cancer Market by Distribution Channel

9.1.4.3.3. Mexico Prostate Cancer Market by End User

9.2. Europe

9.2.1. Europe Prostate Cancer Market by Drug Class

9.2.2. Europe Prostate Cancer Market by Distribution Channel

9.2.3. Europe Prostate Cancer Market by End User

9.2.4. Europe Prostate Cancer Market by Country

9.2.4.1. Germany Prostate Cancer Market

9.2.4.1.1. Germany Prostate Cancer Market by Drug Class

9.2.4.1.2. Germany Prostate Cancer Market by Distribution Channel

9.2.4.1.3. Germany Prostate Cancer Market by End User

9.2.4.2. United Kingdom Prostate Cancer Market

9.2.4.2.1. United Kingdom Prostate Cancer Market by Drug Class

9.2.4.2.2. United Kingdom Prostate Cancer Market by Distribution Channel

9.2.4.2.3. United Kingdom Prostate Cancer Market by End User

9.2.4.3. France Prostate Cancer Market

9.2.4.3.1. France Prostate Cancer Market by Drug Class

9.2.4.3.2. France Prostate Cancer Market by Distribution Channel

9.2.4.3.3. France Prostate Cancer Market by End User

9.2.4.4. Italy Prostate Cancer Market

9.2.4.4.1. Italy Prostate Cancer Market by Drug Class

9.2.4.4.2. Italy Prostate Cancer Market by Distribution Channel

9.2.4.4.3. Italy Prostate Cancer Market by End User

9.2.4.5. Rest of Europe Prostate Cancer Market

9.2.4.5.1. Rest of Europe Prostate Cancer Market by Drug Class

9.2.4.5.2. Rest of Europe Prostate Cancer Market by Distribution Channel

9.2.4.5.3. Rest of Europe Prostate Cancer Market by End User

9.3. Asia Pacific

9.3.1. Asia Pacific Prostate Cancer Market by Drug Class

9.3.2. Asia Pacific Prostate Cancer Market by Distribution Channel

9.3.3. Asia Pacific Prostate Cancer Market by End User

9.3.4. Asia Pacific Prostate Cancer Market by Country

9.3.4.1. China Prostate Cancer Market

9.3.4.1.1. China Prostate Cancer Market by Drug Class

9.3.4.1.2. China Prostate Cancer Market by Distribution Channel

9.3.4.1.3. China Prostate Cancer Market by End User

9.3.4.2. Japan Prostate Cancer Market

9.3.4.2.1. Japan Prostate Cancer Market by Drug Class

9.3.4.2.2. Japan Prostate Cancer Market by Distribution Channel

9.3.4.2.3. Japan Prostate Cancer Market by End User

9.3.4.3. India Prostate Cancer Market

9.3.4.3.1. India Prostate Cancer Market by Drug Class

9.3.4.3.2. India Prostate Cancer Market by Distribution Channel

9.3.4.3.3. India Prostate Cancer Market by End User

9.3.4.4. South Korea Prostate Cancer Market

9.3.4.4.1. South Korea Prostate Cancer Market by Drug Class

9.3.4.4.2. South Korea Prostate Cancer Market by Distribution Channel

9.3.4.4.3. South Korea Prostate Cancer Market by End User

9.3.4.5. Australia Prostate Cancer Market

9.3.4.5.1. Australia Prostate Cancer Market by Drug Class

9.3.4.5.2. Australia Prostate Cancer Market by Distribution Channel

9.3.4.5.3. Australia Prostate Cancer Market by End User

9.3.4.6. Rest of Asia-Pacific Prostate Cancer Market

9.3.4.6.1. Rest of Asia-Pacific Prostate Cancer Market by Drug Class

9.3.4.6.2. Rest of Asia-Pacific Prostate Cancer Market by Distribution Channel

9.3.4.6.3. Rest of Asia-Pacific Prostate Cancer Market by End User

9.4. RoW

9.4.1. RoW Prostate Cancer Market by Drug Class

9.4.2. RoW Prostate Cancer Market by Distribution Channel

9.4.3. RoW Prostate Cancer Market by End User

9.4.4. RoW Prostate Cancer Market by Sub-region

9.4.4.1. Latin America Prostate Cancer Market

9.4.4.1.1. Latin America Prostate Cancer Market by Drug Class

9.4.4.1.2. Latin America Prostate Cancer Market by Distribution Channel

9.4.4.1.3. Latin America Prostate Cancer Market by End User

9.4.4.2. Middle East Prostate Cancer Market

9.4.4.2.1. Middle East Prostate Cancer Market by Drug Class

9.4.4.2.2. Middle East Prostate Cancer Market by Distribution Channel

9.4.4.2.3. Middle East Prostate Cancer Market by End User

9.4.4.3. Africa Prostate Cancer Market

9.4.4.3.1. Africa Prostate Cancer Market by Drug Class

9.4.4.3.2. Africa Prostate Cancer Market by Distribution Channel

9.4.4.3.3. Africa Prostate Cancer Market by End User

More Insights on this report, Speak to Our Analyst: https://www.infiniumglobalresearch.com/market-reports/enquiry/1174

Reasons to Buy this Report:

=> Comprehensive analysis of global as well as regional markets of Prostate Cancer.

=> Complete coverage of all the product types and application segments to analyze the trends, developments, and forecast of market size up to 2030.

=> Comprehensive analysis of the companies operating in this market. The company profile includes an analysis of the product portfolio, revenue, SWOT analysis, and the latest developments of the company.

=> Infinium Global Research- Growth Matrix presents an analysis of the product segments and geographies that market players should focus on to invest, consolidate, expand, and/or diversify.

2nd Floor, Ganadish Empire, Rahatani Chowk, Pimple Saudagar, Pimpri-Chinchwad, Maharashtra 411027

About Infinium Global Research:

Infinium Global Research is a business consulting and market research firm; a group of experts that caters to fulfilling business and market research needs of leading companies in various industry verticals and business segments. The company also serves government bodies, institutes, and non-profit/non-government organizations to meet their knowledge and information needs.

Through our information services and solutions, we assist our clients to improve their performance and assess the market conditions to achieve their organizational goals. Our team of experts and analysts are engaged in continuously monitoring and assessing the market conditions to provide knowledge support to our clients. To help our clients and to stay updated with the advances and inventions in technology, business processes, regulations, and the environment, Infinium often conducts regular meets with industry experts and opinion leaders. Our key opinion leaders are involved in monitoring and assessing the progress in the business environment, so as to offer the best opinion to our clients.

This release was published on openPR.